Contemporary Valvular Interventions

By Nishtha Sodhi Sood, MD, FACC, FSCAI

T-TEER Versus TTVR: Considerations for Transcatheter Tricuspid Valve Therapy Choice

The clinical, anatomic, and echocardiographic criteria for selecting between tricuspid edge-to-edge repair and transcatheter tricuspid valve replacement for tricuspid regurgitation.

By Anita W. Asgar, MD, MSc, and Anene Ukaigwe, MD

The Frontier of Tricuspid Imaging: Utility of TEE and ICE

Tools for starting a new transcatheter tricuspid valve program.

By Nishath Quader, MD; Tsuyoshi Kaneko, MD; and Alan Zajarias, MD

Leaflet Modification in Transcatheter Treatment of Valvular Heart Disease

Rationale and technical tips for aortic leaflet, mitral leaflet, and septal modification with BASILICA, LAMPOON, and SESAME.

By Roosha Parikh, MD, FACC, FASE, FSCCT, FSCMR, FASNC, and Jaffar M. Khan, MD, PhD

Aortic Regurgitation Frontier: Management Options and Future Directions

Epidemiology and pathophysiology considerations for aortic regurgitation, early results and challenges with off-label and dedicated technology, and innovation needs.

By Mohammed Ahmed, MD; Nishath Quader, MD; Marc Sintek, MD; Tsuyoshi Kaneko, MD; and Alan Zajarias, MD

The Scope of Racial, Ethnic, and Socioeconomic Disparities in TAVR Access and Proposed Solutions

The current landscape of health disparities in and access barriers to TAVR and promising collaborative solutions, including the TARGET: Aortic Stenosis Initiative.

By Shreya D. Mehta, BA, BS; Kriyana P. Reddy, BS; Jay S. Giri, MD, MPH; and Ashwin S. Nathan, MD, MS

Contemporary Mitral TEER and Expanding Indications

Expanding beyond the green zone.

By Nidhish Tiwari, MD; Muhammad Asim Shabbir, MD; and Nidhi Madan, MD, MPH

The State of Transcatheter Mitral Valve Implantation

An examination of the past, present, and future of TMVI data, trials, and devices.

By Ruby Satpathy, MD, FACC, FSCAI; Trinath K. Mishra, MD; and Chhabi Satpathy, MD, FACC, FSCAI

Contemporary Considerations in Transcatheter Pulmonary Valve Replacement

Clinical evidence, current and forthcoming technology, and patient-centered decision-making for treating the pulmonary valve.

By Ada C. Stefanescu Schmidt, MD, MSc, and Shabana Shahanavaz, MD, MBBS

Radiation Protection in Structural Heart Disease Procedures: Strategies to Reduce Exposure

A review of newer radiation protection technologies and efforts to reduce radiation exposure to the operator and interventional echocardiographer.

By Poonam Velagapudi, MD, MS; Lucy M. Safi, DO; Ajay J. Kirtane, MD, SM; and James Hermiller, MD

What the Future Holds for Interventional Cardiology: Ownership Models, Compensation, Production, and Beyond

Results of an annual MedAxiom survey rank interventional cardiology among the highest-earning and highest-producing subspecialties, show potential for private equity, and reveal a need to prevent physician burnout.

By Joel Sauer, MBA

An Interview With Kendra J. Grubb, MD, MHA, FACC

Dr. Grubb discusses how her unique background informs her approach to structural intervention and conversations about lifetime aortic stenosis management, the next generation of structural/valvular clinical trials, potential steps to combat women’s heart disease, and more.